← Eichor
Study identifier: NCT06448481 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Aesthetic Outcome of Intra-dermal Versus Transcutaneous Purse-string Closure

Condition: Scarring  ·  Sponsor: University of California, Davis

PhaseNA
Planned participants73
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to determine whether intra-dermal versus transcutaneous purse-string closures have similar scar cosmesis and post-operative complications. The investigators will use a split wound model, where half of the wound will be closed with intra-dermal purse-string sutures and the other half will be closed with a transcutaneous purse-string sutures. Three-months post-surgery, the scar will be evaluated via the patient observer scar assessment scale (POSAS), a validated scar instrument, as well as the trace-to-tape method, an objective outcome measure for linear postoperative scars. Any adverse events will also be recorded.

This description comes directly from the study's public registry record.

Talk to the study team

Salsala Nasim, BS  ·  916-551-2636  ·  sanasim@health.ucdavis.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of California, Davis - Dermatology DepartmentSacramento, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06448481